Abstract
Two hundred sixteen abstracts were selected for presentation at the 2024 American College of Medical Toxicology (ACMT) Annual Scientific Meeting on April 12–14, 2024, in Washington, DC. The quality and breadth of toxicology scholarship continues to grow as our field expands. The complete 2024 ASM abstract book in the April issue of JMT includes original research studies from around the world and the ToxIC Investigators Consortium, clinically significant case reports describing toxicologic phenomena, and selected encore research presentations from other scientific meetings.
Keywords: Abstracts, Annual Scientific Meeting, Toxicology Investigators Consortium, Medical Toxicology Foundation
Introduction
The American College of Medical Toxicology (ACMT) received a record breaking 263 eligible abstracts for consideration for presentation at the 2024 Annual Scientific Meeting (ASM) including 147 original research studies and 116 case reports. This represents a 20% increase in submissions from 2020 and demonstrates the impressive growth of the ASM. Each abstract was reviewed in a blinded fashion by a minimum of three Abstract Review Committee members and was independently scored based on the clinical question, innovation, data source, analytic method, results, conclusions, and presentation of the abstract. A total of 216 abstracts were accepted for presentation.
As with previous years, the quality of toxicology research continues to grow as our field expands, and the impact of the selected abstracts and subsequent manuscripts will certainly reach far beyond our specialty. The breadth and variety of these studies should be acknowledged and celebrated: Day 1 of ASM will include diverse topics including pediatric opioid exposures followed by a novel carbon monoxide antidote. The struggle to diagnose and treat classic poisonings such as toxic alcohols and salicylates remains real as researchers will describe novel diagnostic assays for ethylene glycol and impediments to hemodialysis use in severely poisoned salicylate patients. Day 2 will introduce attendees to the role artificial intelligence can play in toxicology, before transitioning to envenomations and antivenom. The conference will conclude with lightening platforms that discuss antidotes including N-acetylcysteine, octreotide, and calcium…truly a dizzying array of topics that reinforces what every toxicologist intuitively knows, “All things are poison, and nothing is without poison.”
Supplementing the original research contributions this year will be four different tracks running concurrently that will allow attendees to tailor their conference experience. Tracks include Environmental and Occupational Medicine, Addiction Medicine, Diversity, Equity, and Inclusion, and Research and will consist of symposia and panel discussions by some of the world’s most accomplished speakers in our field. These combined with ASM favorites like Case-Based Conundrums, the MTF Shark Tank Research Forum, and Open Mic Competition promise to provide attendees with an unrivaled experience.
Finally, we would be remise not to highlight that this year’s ASM is taking place in Washington, DC. With this comes the ability to recruit speakers from the highest levels of government, including Dr. Nora Volkow, the director of the National Institute on Drug Abuse, who will be delivering the Donovan Lectureship on the role of NIDA in combating the opioid epidemic. With policy-based content interspersed throughout the conference, the relationship between government and toxicology will be front and center. In addition, April is a great time to check out the National Cherry Blossom festival near the National Mall.
This work would not be possible without the hard work and diligence of our abstract reviewers: Gillian Beauchamp, Mary Billington, Adam Blumenberg, Marielle Brenner, Keith Burkhart, Vincent Calleo, Joseph Carpenter, Stephanie Carreiro, Peter Chai, Richard Chen, James Chenoweth, Neeraj Chhabra, Jon Cole, Nick Connors, Riley Hartmann, Hannah Hays, Rob Hendrickson, Michelle Hieger, Diane Hindman, Louise Kao, Kenneth Katz, Ziad Kazzi, Joseph Kennedy, Andrew King, JoAn Laes, Eric Lavonas, Jacob Lebin, Vincent Lee, Michael Levine, Dave Liss, Alex Manini, Kevin Maskell, Christopher Meadan, Elissa Moore, Babak Mostafazadeh, Mark Mycyk, Travis Olives, Anthony Pizon, Patricia Rosen, Jonathan Schimmel, Evan Schwarz, Daniel Sessions, Manoj Tyagi, Shawn Varney, Steven Walsh, Richard Wang, Christopher James Watson, Sage Wiener, Brandon Wills, and Luke Yip.
Additionally, we would like to thank Shana Kusin, the chair of abstract review mentorship program, and the fellows who participated in the fourth year of the abstract review mentorship program: Colleen Cowdery, John DelBianco, Matthew Dernbach, Damilola Idowu, Michael Khoury, Christopher Mitchell, and Ben Weigel.
Lastly, we would like to thank the contribution of the ACMT staff, Alison Meyn, Adrienne Dunavin, and Lucinda Gonzales, who led the process.
Congratulations to all the contributors whose work will be presented at the 2024 ACMT Annual Scientific Meeting in Washington, DC.
We look forward to a great meeting,
Michael Toce, MD, MS, Abstract Review Chair; Charlotte Goldfine, MD, Abstract Review Co-Chair; Maryann Amirshahi, PharmD, MD, MPH, PhD, FACMT, Chair, ACMT Research Committee.
Sources of Funding
None.
Declarations
Conflicts of Interest
None.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.